This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Sanofi. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Elodie Barbagallo: Innovator in Therapeutic Compounds
Introduction
Elodie Barbagallo is a prominent inventor based in Paris, France. She has made significant contributions to the field of therapeutic compounds, holding 2 patents that showcase her innovative spirit and dedication to advancing medical science.
Latest Patents
Her latest patents include compounds corresponding to a specific formula that involves divalent (C-C)alkylene radicals and various substituents. These compounds have potential therapeutic applications, highlighting her focus on developing new treatments. Another notable patent involves novel substituted 1-benzylcinnolin-4(1H)-one derivatives that exhibit affinity for cannabinoid CB receptors, further emphasizing her commitment to exploring new therapeutic avenues.
Career Highlights
Elodie Barbagallo is currently associated with Sanofi, a leading global healthcare company. Her work at Sanofi has allowed her to collaborate with other talented professionals in the field, contributing to groundbreaking research and development.
Collaborations
Some of her notable coworkers include Murielle Rinaldi-Carmona and Pascale Roux. Their collaborative efforts have played a crucial role in advancing their shared goals in therapeutic innovation.
Conclusion
Elodie Barbagallo's contributions to the field of therapeutic compounds reflect her innovative mindset and commitment to improving healthcare. Her patents and collaborations underscore her role as a key figure in the ongoing pursuit of medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile